Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (2) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Withdrawn applications Remove Withdrawn applications filter Referrals Remove Referrals filter

Product number

Referral name

Referral status

European Commission final decision (2) Apply European Commission final decision filter

Referral type

Article 20 procedures (2) Apply Article 20 procedures filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC Remove PRAC-CHMP-EC filter PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) Remove Centrally authorised product(s) filter Centrally and nationally authorised products (mixed) (1) Apply Centrally and nationally authorised products (mixed) filter

Referral PRAC recommendation

Risk minimisation measures Remove Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Biosimilar Remove Biosimilar filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Additional monitoring (6) Apply Additional monitoring filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

2 results

Remove all filtersRemove all filters

Medicine Referrals Remove Referrals filter Withdrawn applications Remove Withdrawn applications filter

Medicine type Biosimilar Remove Biosimilar filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Accelerated assessment Remove Accelerated assessment filter

Referral PRAC recommendation Risk minimisation measures Remove Risk minimisation measures filter

Referral authorisation model Centrally authorised product(s) Remove Centrally authorised product(s) filter

Referral decision making model PRAC-CHMP-EC Remove PRAC-CHMP-EC filter

Sort by

List item

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)

daclatasvir, dasabuvir, sofosbuvir, ledipasvir, simeprevir, ombitasvir, paritaprevir, ritonavir, associated names: Sovaldi, Olysio, Viekirax, Harvoni, Exviera, Daklinza, Article 20 procedures
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 23/02/2017, Last updated: 09/03/2017
List item

Referral: Iclusig

ponatinib, associated names: Iclusig, Article 20 procedures
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 15/01/2015, Last updated: 02/03/2015

2 results

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)

Referral: Iclusig